ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitreo-papillary Traction as an Entity Identified by Optical Coherence Tomography (OCT).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03460600
Recruitment Status : Completed
First Posted : March 9, 2018
Last Update Posted : March 9, 2018
Sponsor:
Information provided by (Responsible Party):
Dr. Shawkat Michel, Dr. S.S. Michel Clinic

Brief Summary:
Optical Coherence Tomography (OCT) is a relatively new imaging technique in ophthalmology. This clear and documented imaging identified new diseases/ observations that were not previously known.

Condition or disease Intervention/treatment
Tomography, Optical Coherence Other: Optical Coherence Tomography (OCT)

Detailed Description:
In ophthalmology vitreo-macular adhesion, vitreo-macular traction and posterior vitreous detachment were recognized entities for a long time. On the other hand vitreo-papillary adhesion/ traction is a fairly new concept in ophthalmology that became known after the use of OCT in ophthalmology imaging. Reasons, effects and ways of treatment of vitreo-papillary traction will take some time to evolve. The case study in which this traction was documented was initiated by an observation of a persistent, tiny single retinal hemorrhage above the optic disc of an eye. The patient was completely asymptomatic because of the vitreo-papillary traction but the OCT documentation of the case was so clear and striking.

Study Type : Observational
Actual Enrollment : 1 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: OCT Documents Vitreo-papillary Traction
Actual Study Start Date : February 27, 2018
Actual Primary Completion Date : February 28, 2018
Actual Study Completion Date : February 28, 2018

Intervention Details:
    Other: Optical Coherence Tomography (OCT)
    Optical Coherence Tomography is a fairly new imaging technique in ophthalmology


Primary Outcome Measures :
  1. Tomography, Optical Coherence (OCT) [ Time Frame: through study completion, usually one day. ]
    Vitreo-papillary traction (VPT) is a relatively new finding in ophthalmology that became very well known and documented by Optical Coherence Tomography (OCT)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
any himan subject that is found to have VPT by OCT.
Criteria

Inclusion Criteria:

  • any human subject that is found to have VPT by OCT.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03460600


Locations
Canada, Alberta
Dr. S.S. Michel Clinic
Edmonton, Alberta, Canada, T5R 5W9
Sponsors and Collaborators
Dr. S.S. Michel Clinic
Investigators
Principal Investigator: shawkat michel Dr. S.S. Michel Clinic Edmonton, Alberta Canada

Responsible Party: Dr. Shawkat Michel, ophthalmologist, Dr. S.S. Michel Clinic
ClinicalTrials.gov Identifier: NCT03460600     History of Changes
Other Study ID Numbers: vitreo-papillary traction
First Posted: March 9, 2018    Key Record Dates
Last Update Posted: March 9, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: if someone is interested in this case he/ she needs to send a new/ previously unused USB and I will transfer OCT images available to him/ her.
Supporting Materials: Clinical Study Report (CSR)
Time Frame: starting now for three months till May 31, 2018.
Access Criteria: send a new USB and a postage paid return envelop.
URL: http://

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No